Prometic Life Sciences (PLI) is a very low entry opportunity in a Canadian stock that will be very big in the orphan drug arena (as well as in protein seperation from plasma and in fibrosis). The risk reward is far far better then AEGR at this time. PLI is just now breaking even and has large growth projected for the near future. See this video on BNN (the Canadian TV equivalent of CNBC or Bloomberg TV) from late this last Friday which I will give in Part II so if Yahoo kills the post the entire post will not be lost. Well worth your time to do the DD.